|
US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
|
US5204098A
(en)
|
1988-02-16 |
1993-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-protein conjugates
|
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
IL98715A0
(en)
|
1990-08-13 |
1992-07-15 |
American Cyanamid Co |
Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
US5425946A
(en)
|
1992-08-31 |
1995-06-20 |
North American Vaccine, Inc. |
Vaccines against group C Neisseria meningitidis
|
|
PL175595B1
(pl)
|
1992-08-31 |
1999-01-29 |
North American Vaccine Inc |
Antygenowy/immunogenny koniugat do wytwarzania szczepionki przeciwko infekcji N.meningitidis, sposób wytwarzania antygenowego/immunogennego koniugatu oraz szczepionka przeciwko infekcji N.meningitidis
|
|
NL9201716A
(nl)
|
1992-10-02 |
1994-05-02 |
Nederlanden Staat |
Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
|
|
US5698438A
(en)
|
1994-10-18 |
1997-12-16 |
Oregon Health Sciences University |
Bacterial hemoglobin receptor gene
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
WO1998053851A1
(en)
|
1997-05-28 |
1998-12-03 |
University Of Iowa Research Foundation |
Laft mutants of pathogenic gram-negative bacteria
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
US6645503B1
(en)
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
|
ES2304065T3
(es)
|
1998-05-01 |
2008-09-01 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenos y composiciones de neisseria meningitidis.
|
|
CN1263510C
(zh)
|
1998-08-19 |
2006-07-12 |
巴克斯特健康护理股份有限公司 |
多糖－蛋白质缀合物或寡糖－蛋白质缀合物、其制备方法及其应用
|
|
CA2347849C
(en)
|
1998-10-22 |
2013-06-25 |
The University Of Montana |
Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
|
|
EP1127137B2
(en)
|
1998-11-03 |
2013-12-25 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Lps with reduced toxicity from genetically modified gram negative bacteria
|
|
WO2000033882A1
(en)
|
1998-12-04 |
2000-06-15 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
A vi-repa conjugate vaccine for immunization against salmonella typhi
|
|
MY125387A
(en)
|
1999-03-19 |
2006-07-31 |
Smithkline Beecham Biologicals S A |
Vaccine
|
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
ES2477194T3
(es)
|
1999-04-30 |
2014-07-16 |
Novartis Vaccines And Diagnostics S.R.L. |
Ant�genos neisseriales conservados
|
|
US6531131B1
(en)
|
1999-08-10 |
2003-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugate vaccine for Neisseria meningitidis
|
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
ATE460484T1
(de)
|
1999-11-29 |
2010-03-15 |
Novartis Vaccines & Diagnostic |
85 kda antigen von neisseria
|
|
WO2001055182A1
(en)
|
2000-01-25 |
2001-08-02 |
The University Of Queensland |
PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
MX339524B
(es)
*
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
EP1476197B1
(en)
|
2002-02-22 |
2009-01-07 |
National Research Council Of Canada |
Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
|
|
DK1490409T3
(da)
|
2002-03-26 |
2009-03-23 |
Novartis Vaccines & Diagnostic |
Modificerede saccharider med forbedret stabilitet i vand
|
|
WO2004014417A2
(en)
|
2002-08-02 |
2004-02-19 |
Glaxosmithkline Biologicals Sa |
Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis
|
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
GB0227346D0
(en)
*
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
JP2006525330A
(ja)
|
2003-04-16 |
2006-11-09 |
ワイエス・ホールディングス・コーポレーション |
髄膜炎菌性疾患の予防および処置のための新規免疫原性組成物
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
AU2006234984B2
(en)
|
2005-04-08 |
2011-10-13 |
Wyeth |
Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
KR102017842B1
(ko)
|
2005-04-08 |
2019-09-03 |
와이어쓰 엘엘씨 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
JP2008543907A
(ja)
|
2005-06-27 |
2008-12-04 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
EA014107B1
(ru)
|
2005-12-22 |
2010-10-29 |
Глаксосмитклайн Байолоджикалс С.А. |
Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
CA2654706A1
(en)
|
2006-06-12 |
2007-12-21 |
Nathalie Devos |
Neisseria meningitidis lipooligosaccharide vaccine
|
|
CN102648979B
(zh)
|
2006-10-10 |
2014-05-14 |
惠氏公司 |
肺炎链球菌3型多糖的纯化
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
EP2185576A4
(en)
|
2007-08-02 |
2011-01-12 |
Childrens Hosp & Res Ct Oak |
FHBP- AND LPXL1-BASED VESICIUM VACCINES FOR BROADBAND PROTECTION AGAINST NEISSERIA MENINGITIDIS-RELATED DISEASES
|
|
AU2009215364B2
(en)
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
|
WO2010109323A1
(en)
*
|
2009-03-24 |
2010-09-30 |
Novartis Ag |
Adjuvanting meningococcal factor h binding protein
|
|
AU2011268507B2
(en)
|
2010-06-25 |
2014-08-14 |
Novartis Ag |
Combinations of meningococcal factor H binding proteins
|
|
DK3831406T3
(da)
|
2010-08-23 |
2024-06-17 |
Wyeth Llc |
Stabile formuleringer af Neisseria-Meningitidis-RLP2086-antigener
|
|
ES2728282T3
(es)
|
2010-09-10 |
2019-10-23 |
Wyeth Llc |
Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis
|